Electromotive drug-administration: A pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity

Neurourology and Urodynamics

Volumn 28, Issue 3, 2009, Pages 209-213

  Bach, Peter ^a   Wormland, Renate T ^a   Möhring, Comelia ^a   Goepel, Mark ^a  

^a Klinikum Niederberg   (Germany)

Author keywords

EMDA; Overactive bladder; Urodynamics

Indexed keywords

ADRENALIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; DEXAMETHASONE SODIUM PHOSPHATE; LIDOCAINE;

ADULT; ARTICLE; BLADDER CAPACITY; DETRUSOR MUSCLE; DIURNAL ENURESIS; DRUG ADMINISTRATION; DRUG EFFICACY; DRUG RESPONSE; DRUG TREATMENT FAILURE; ELECTROMOTIVE DRUG ADMINISTRATION; ERYTHEMA; FEMALE; HUMAN; IDIOPATHIC DISEASE; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; MALE; MICTURITION; MINIMALLY INVASIVE PROCEDURE; NOCTURIA; OVERACTIVE BLADDER; PILOT STUDY; QUALITY OF LIFE; TREATMENT DURATION; URGE INCONTINENCE; URODYNAMICS;

AGED; ANESTHETICS, LOCAL; ANTI-INFLAMMATORY AGENTS; CHOLINERGIC ANTAGONISTS; DEAMINO ARGININE VASOPRESSIN; DEXAMETHASONE; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; LIDOCAINE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; QUALITY OF LIFE; QUESTIONNAIRES; RENAL AGENTS; URINARY BLADDER; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE, URGE; URINATION; URODYNAMICS;

EID: 67649993264     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20624     Document Type: Article

References (21)

1. Abrams AM. Reviewing the ICS 2002 terminology report: The ongoing debate. Neurourol Urodyn 2006;25:294.
2. Hannestad YS, Rortveit G, Sandvik H, et al. A community-based epidemiological survey of female urinary incontinence: The Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trondelag. J Clin Epidemiol 2000;53:1150.
3. Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study. Eur Urol 2006;50:1306.
4. Carlson KV, Rome S, Nitti VW. Dysfunctional voiding in women. J Urol 2001;165:143.
5. Apodaca G. The uroepithelium: Not just a passive barrier. Traffic 2004;5:117.
6. Massad CA, Kogan BA, Trigo-Rocha FE. The pharmacokinetics of intravesical and oral oxybutynin chloride. J Urol 1992;148:595.
7. Giannantoni A, Di Stasi SM, Chancellor MB, et al. New frontiers in intravesical therapies and drug delivery. Eur Urol 2006;50:1183.
8. Gurpinar T, Truong LD, Wong HY, et al. Electromotive drug administration to the urinary bladder: An animal model and preliminary results. J Urol 1996;156:1496.
9. Fontanella UA, Rossi CA, Stephen RL. Bladder and, urethral anaesthesia with electromotive drug administration (EMDA): A technique for invasive endoscopic procedures. Br J Urol 1997;79:414.
10. Di Stasi SM, Giannantoni A, Massoud R, et al. Electromotive versus passive diffusion of mitomycin C into human bladder wall: Concentration-depth profiles studies. Cancer Res 1999;59:4912.
11. Riedl CR, Knoll M, Plas E, et al. Intravesical electromotive drug administration technique: Preliminary results and side effects. J Urol 1998;159:1851.
12. Rose AE, Payne CK, Azevedo K. Pilot study of the feasibility of in-office bladder distention using electromotive drug administration (EMDA). Neurourol Urodyn 2005;24:254.
13. Rose AE, Azevedo KJ, Payne CK. Office bladder distention with electromotive drug administration (EMDA) is equivalent to distention under general anesthesia (GA). BMC Urol 2005;5:14.
14. Kelleher CJ, Cardozo LD, Toozs-Hobson PM. Quality of life and urinary incontinence. Curr Opin Obstet Gynecol 1995;7:404.
15. Goepel M, Steinwachs KC. How do medications used to treat urinary incontinence affect the cerebral function of the elderly?. Urologe A 2007;46:387.
16. Macdonald R, Fink HA, Huckabay C, et al. Botulinum toxin for treatment of urinary incontinence due to detrusor overactivity: A systematic review of effectiveness and adverse effects. Spinal Cord 2007; 45:535-41.
17. Lose G, Norgaard JP. Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor. BJU Int 2001;87:767.
18. Hinkel A, Pannek J. Transient ischemic attack after electromotive drug administration for chronic non-infectious cystitis: Report of two similar cases. Neurourol Urodyn 2004;23:180.
19. Appell RA, Abrams P, Drutz HP, et al. Treatment of overactive bladder: Long-term tolerability and efficacy of tolterodine. World J Urol 2001;19: 141.
20. Tempest HV, Dixon AK, Turner WH, et al. P2X and P2X receptor expression in human bladder urothelium and changes in interstitial cystitis. BJU Int 2004; 93:1344-8.
21. Elneil S, Skepper J, Kidd N, et al. Distribution of P2X1 and P2X3 receptors in the rat and human urinary bladder. Pharmacology 2001;63:100.